Arixtra and Haemoglobin decreased - a phase IV clinical study of FDA data
Summary:
Haemoglobin decreased is reported as a side effect among people who take Arixtra (fondaparinux sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lovenox, and have Pulmonary embolism.
The phase IV clinical study analyzes which people have Haemoglobin decreased when taking Arixtra. It is created by eHealthMe based on reports of 9,755 people who have side effects when taking Arixtra from the FDA, and is updated regularly.
What is Arixtra?
Arixtra has active ingredients of fondaparinux sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 9,830 Arixtra users. Check the latest studies of Arixtra.
What is Haemoglobin decreased?
Haemoglobin decreased is found to be associated with 2,402 drugs and 3,136 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
9,755 people reported to have side effects when taking Arixtra.
Among them, 480 people (4.92%) have Haemoglobin decreased.
Among these 480 people:
How long have people been on Arixtra when they have Haemoglobin decreased? *
What is the gender of people who have Haemoglobin decreased when taking Arixtra? *
What is the age of people who have Haemoglobin decreased when taking Arixtra? *
What are other drugs people take besides Arixtra? *
What are other side effects people have besides Haemoglobin decreased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Arixtra and have Haemoglobin decreased?
- Check whether Haemoglobin decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Arixtra:
- Arixtra (9,830 reports)
Haemoglobin decreased treatments and more:
- Haemoglobin decreased (141,785 reports)
How severe was Haemoglobin decreased and when was it recovered:
Expand to all the drugs that have ingredients of fondaparinux sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Arixtra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Haemoglobin decreased:
- Haemoglobin decreased (2,402 drugs)
Browse all the conditions that are associated with Haemoglobin decreased:
- Haemoglobin decreased (3,136 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fondaparinux sodium (the active ingredients of Arixtra) and Arixtra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aspirin cause Staphylococcus Test Positive? - 9 seconds ago
- Oesophageal Hypomotility and drugs of ingredients of etoposide - 12 seconds ago
- Farxiga and Voltaren drug interactions for women aged 60+ - 13 seconds ago
- Drug interactions of Vitamin D and Soy Isoflavones - 16 seconds ago
- Benadryl and Cardiac Failure Congestive for Men aged 40-49 - 16 seconds ago
- Could Calcitriol cause Diabetes? - 17 seconds ago
- Drug interactions of Multivitamin and Skelaxin - 18 seconds ago
- Ranolazine and Simvastatin drug interactions for women aged 50-59 - 19 seconds ago
- Fludara and Confusion Aggravated for Men aged 60+ - 20 seconds ago
- Flonase and K-Tab drug interactions for women aged 50-59 - 21 seconds ago